The MBA/Biopharmaceutical Commercialization (M.B.A.) at Thomas Jefferson University is engineered for ambitious professionals aiming to lead in the dynamic biopharmaceutical sector, particularly in the commercialization of advanced medicines like cell and gene therapies. This postgraduate degree equips you with a comprehensive understanding of key strategies, analytics, regulations, and quality standards essential for navigating this complex industry. You will gain specialized knowledge in areas such as recombinant vaccines and monoclonal antibodies, preparing you to address critical opportunities and challenges within the biopharma landscape.
You will engage in a rigorous, full-time, on-campus learning experience over two years, directly benefiting from the unique collaboration with the Jefferson Institute of Bioprocessing (JIB). This partnership provides access to industry-standard equipment and the NIBRT curriculum, offering unparalleled practical insights. Through modules like Biopharmaceutical Commercialization: Strategy & Analytics and Biopharmaceuticals & Biologics: Regulatory & Quality, you will develop critical analytical and strategic skills. You will graduate prepared for impactful roles in biopharmaceutical strategy, analytics, regulatory affairs, and commercial operations, ready to drive innovation in a growing global market.